Депрессия, тревога и ишемическая болезнь сердца: что необходимо знать кардиологу?

1. Malzberg B. Mortality among patients with involutional melancholia. Am J Psychiatry 1937; 93:1231–8.
2. Review Panel on Coronary-Prone Behavior and Coronary Heart Disease. Coronary-prone behavior and coronary heart disease: a critical review. Circulation 1981; 63: 1199–215.
3. Friedman M, Thoresen CE, Gill JJ et al. Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project. Am Heart J 1986; 112: 653–65.
4. Booth-Kewley S, Friedman HS. Psychological predictors of heart disease: a quantitative review. Psychol Bull 1987; 101: 343–62.
5. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–52.
6. Ustun TB, Sartorius N. Mental Illness in General Health Care: An International Study. Chichester-Willey, 1995.
7. Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19.
8. Steffens DC, Skoog I, Norton MC et al. Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch Gen Psychiatry 2000; 57: 601–17.
9. Regier DA, Narrow WE, Rae DS et al. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993; 50: 85–94.
10. Belsher G, Costello CG. Relapse after recovery from unipolar depression: a critical review. Psychol Bull 1988; 104: 84–96.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. 4th ed. Washington,DC: American Psychiatric Association; 2000.
12. Carney RM, Rich MW, Tevelde A et al. Major depressive disorder in coronary artery disease. Am J Cardiol 1987; 60: 1273–5.
13. Оганов Р.Г., Погосова Г.В., Шальнова С.А., Деев А.Д. Депрессивные расстройства в общемедицинской практике по данным исследования КОМПАС: взгляд кардиолога. Кардиология. 2005; 8: 38–44.
14. Thombs BD, Bass EB, Ford DE et al. Prevalence of Depression in Survivors of Acute Myocardial Infarction. Review of the Evidence J Gen Intern Med 2006; 21: 30–8.
15. Чазов Е.И., Оганов Р.Г., Погосова Г.В. и др. Клинико-эпидемиолОгическая прОграмма изучения депРессии в карДиологической практИке: у больНых Артериальной гиперТонией и ишемической болезнью сердцА (КООРДИНАТА): результаты многоцентрового исследования. Кардиология. 2007; 3: 28–37.
16. Glassman AH, Bigger JT, Gaffney M et al. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 2006; 63: 283–8.
17. Anda R, Williamson D, Jones D et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993; 4: 285–94.
18. Rugulies R. Depression as a predictor for coronary heart disease. Am J Prev Med 2002; 23: 51–61.
19. Thurston R, Kubzansky LD, Kawachi I, Berkman L. Do depression and anxiety mediate the link between educational attainment and coronary heart disease? Psychosom Med 2006; 68: 25–32.
20. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005; 28: 1339–45.
21. Empana JP, Jouven X, Lemaitre RN et al. Clinical depression and risk of out-of-hospital cardiac arrest. Arch Intern Med 2006; 166: 195–200.
22. Empana JP, Sykes DH, Luc G et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005; 111: 2299–305.
23. Kamphuis MH, Kalmijn S, Tijhuis MA et al. Depressive symptoms as risk factor of cardiovascular mortality in older European men: the Finland, Italy and Netherlands Elderly (FINE) study. Eur J Cardiovasc Prev Rehabil 2006; 13: 199–206.
24. Marzari C, Maggi S, Manzato E et al. Depressive symptoms and development of coronary heart disease events: the Italian longitudinal study on aging. J Gerontol A Biol Sci Med Sci 2005; 60: 85–92.
25. Rowan PJ, Haas D, Campbell JA et al. Depressive symptoms have an independent, gradient risk for coronary heart disease incidence in a random, population-based sample. Ann Epidemiol 2005; 15: 316–20.
26. Sundquist J, Li X, Johansson SE, Sundquist K. Depression as a predictor of hospitalization due to coronary heart disease. Am J Prev Med 2005; 29:428–33.
27. Williams SA, Kasl SV, Heiat A et al. Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med 2002; 64: 6–12.
28. Wulsin LR, Evans JC, Vasan RS et al. Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study. Psychosom Med 2005; 67: 697–702.
29. Rozanski A, Blumenthal JA, Davidson KW et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005; 45: 637–51.
30. Frasure-Smith N, Lesperance F, Juneau M et al. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 1999; 61: 26–37.
31. van Melle JP, de Jonge P, Spijkerman TA et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66: 814–22.
32. Bush DE. Post-Myocardial Infarction Depression. Evidence report/technology assessment, no. 123. Ref Type: Serial (Book, Monograph). 5–1–2005. Rockville, Md: AHRQ publication, US Department of Health and Human Services; 2005.
33. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105: 1049–53.
34. Bush DE, Ziegelstein RC, Tayback M et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001; 88: 337–41.
35. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a metaanalysis. Psychosom Med 2004; 66: 802–13.
36. Чазов Е.И., Оганов Р.Г., Погосова Г.В. и др. Депрессивная симптоматика ухудшает прогноз у больных артериальной гипертонией и ишемической болезнью сердца: первые результаты проспективного этапа российского многоцентрового исследования КООРДИНАТА. Кардиология. 2007; 10: 24–30.
37. Rutledge T, Reis VA, Linke SE et al. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006; 48: 1527–37.
38. Blumenthal JA, Lett HS, Babyak MA et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003; 362: 604–9.
39. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. BMJ (Clin Res Ed) 1987; 295: 297–9.
40. Albert CM, Chae CU, Rexrode KM et al. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 2005; 111: 480–7.
41. Eaker ED, Pinsky J, Castelli WP. Myocardial infarction and coronary death among women: psychosocial predictors from a 20-year follow-up of women in the Framingham Study. Am J Epidemiol 1992; 135: 854–64.
42. Eaker ED, Sullivan LM, Kelly-Hayes M et al. Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study. Psychosom Med 2005; 67: 692–6.
43. Haines A, Cooper J, Meade TW. Psychological characteristics and fatal ischemic heart disease. Heart 2001; 85: 385–9.
44. Kawachi I, Colditz GA, Ascherio A et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994; 89: 1992–7.
45. Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994; 90: 2225–9.
46. Kubzansky LD, Kawachi I, Spiro A 3rd et al. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation 1997; 95: 818–24.
47. Nicholson A, Fuhrer R, Marmot M. Psychological distress as a predictor of CHD events in men: the effect of persistence and components of risk. Psychosom Med 2005; 67: 522–30.
48. Ringback Weitoft G, Rosen M. Is perceived nervousness and anxiety a predictor of premature mortality and severe morbidity? A longitudinal follow up of the Swedish survey of living conditions. J Epidemiol Community Health 2005; 59: 794–8.
49. Thurston R, Kubzansky LD, Kawachi I, Berkman L. Do depression and anxiety mediate the link between educational attainment and coronary heart disease? Psychosom Med 2006; 68: 25–32.
50. Chang PP, Ford DE, Meoni LA et al. Anger in young men and subsequent premature cardiovascular disease: the precursors study. Arch Intern Med 2002; 162: 901–6.
51. Eaker ED, Sullivan LM, Kelly-Hayes M et al. Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation 2004; 109: 1267–71.
52. Kawachi I, Sparrow D, Spiro A et al. A prospective study of anger and coronary heart disease. The Normative Aging Study. Circulation 1996; 94: 2090–5.
53. Williams JE, Nieto FJ, Sanford CP, Tyroler HA. Effects of an angry temperament on coronary heart disease risk: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2001; 154: 230–5.
54. Williams JE, Paton CC, Siegler IC et al. Anger proneness predicts coronary heart disease risk: prospective analysis from the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2000; 101: 2034–9.
55. Beck AT, Ward CH, Mendelsohn M. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–71.
56. Hautzinger M. The CES-D scale: a depression-rating scale for research in the general population. Diagnostica 1988; 34: 167–73.
57. Zigmond AS, Snaith RP. Hospital Anxiety and Depression Scale. Acta Psyhiat Scand 1983; 67: 361–70.
58. Андрющенко А.В., Дробижев М.Ю., Добровольский А.В. Сравнительная оценка шкал CESD, BDI и HADS в диагностике депрессий в общемедицинской практике. Журн. неврол. и психиатр. 2003; 5: 11–6.
59. Berkman LF, Blumenthal J, Burg M et al. ENRICHD investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106–16.
60. Glassman AH, O'Connor CM, Califf RM et al. Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701–9.
61. Lesperance F, Frasure-Smith N, Koszycki D et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Candaian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007; 297: 367–79.
62. van den Brink RH, Van Melle JP, Honig A et al. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT). Am Heart J 2002; 144: 219–25.
63. Blumenthal JA, Sherwood A, Rogers SD et al. Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study-rationale, design, and methodological issues. Clin Trials 2007; 4: 548–59.
64. Shah SU, Iqbal Z, White A, White S. Heart and mind: (2) psychotropic and cardiovascular therapeutics. Postgrad Med J 2005; 81: 33–40.
65. Cassano GB, De Wilde J, Ferreira L et al. Can a 5-HT uptake enhancerbe an antidepressant. A double-blind study of tianeptine and imipramine in the treatment of major depressed bipolar disorder. Eur Psychiatry 1996; 11: 254–9.
66. Invernizzi G, Aguglia E, Bertolino A et al. The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicenter study vs amitriptyline. Neuropsychobiology 1994; 30: 85–93.
67. Kasper S, Olie JP. A meta-analysis of randomized controlled trials of tianeptine versus SSPI in the short-term treatment of depression. Eur Psychiat 2002; 17 (3) Suppl.: 331–40.
68. Guelfi JD, Pichot P, Dreyfus JF. Efficacy of tianeptine in anxious-depressed patients. Results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology 1989; 22: 41–8.
69. Lˆoo H, Malka R, Defrance R et al. Tianeptine and amitriptyline: controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology 1988; 19: 79–85.
70. Чазов Е.И., Оганов Р.Г., Погосова Г.В. и др. Клинико-эпидемиологическая программа изучения депрессии в кардиологической практике: у больных артериальной гипертонией и ишемической болезнью сердца (КООРДИНАТА): первые результаты многоцентрового исследования. Кардиология. 2005; 11: 4–11.
71. Дробижев М.Ю., Сыркин А.Л., Полтавская М.Г. и др. Опыт применения коаксила (тианептина) в лечении тревожных депрессий у больных ишемической болезнью сердца.
72. Guelfi JD, Dulcire C, Le Moine P, Tafani A. Clinical safety and efficacy of tianeptine in 1,858 depressed patients treated in general practice. Neuropsychobiology 1992; 25 (3): 140–8.
73. Погосова Г.В., Жидко Н.И., Красницкий В.Б. и др. Клиническая эффективность тианептина у больных ишемической болезнью сердца с коморбидной депрессией. Кардиология. 2004; 3: 20–4.
74. Стаценко М.Е., Рыбак В.А., Говоруха О.А. Коррекция тревожно-депрессивных расстройств тианептином у больных с сердечной недостаточностью в раннем постинфарктном периоде. Кардиология. 2005; 12: 40–52.
75. Васюк Ю.А., Лебедев А.В., Довженко Т.В., Семиглазова М.В. Аффективные расстройства и инфаркт миокарда: клинико-функциональные взаимосвязи и возможности антидепрессивной терапии тианептином. Кардиология. 2008; 12: 34–41.